Flublok Trivalent Northern Hemisphere Injection
Product Images NDC 49281-725

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Flublok Trivalent Northern Hemisphere (NDC 49281-725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Pasteur Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

This is the information for the Influenza Vaccine Flublok®. It is preservative-free and is intended for intramuscular use as a 0.5 mL single-dose. The manufacturer is Protein Sciences Corp. and the product has a specific NDC code.*

FDA Label Image

Principal Display Panel (0.5 mL Syringe Carton)

This is a description of the Influenza Vaccine Flublok®. It contains a formulation of recombinant hemagglutinin from specific influenza virus strains and is stored refrigerated between 2°C to 8°C (36°F to 46°F). Each 0.5 mL dose is formulated with 45 mcg of recombinant HA and does not contain preservatives. The vaccine is for intramuscular use for individuals 18 years of age and older, and each package includes 10 single-dose pre-filled syringes. The product should not be frozen, and syringes should be protected from light. The manufacturing information indicates that it is produced by Protein Sciences Corporation and distributed by Sanofi Pasteur Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.